Menu

Author Sues Journal

The American Diabetes Association faces a lawsuit after journal editors express concern over several papers.

Feb 10, 2015
Kerry Grens

WIKIMEDIA, BILL BRADFORDA professor from the State University of Campinas in São Paolo, Brazil, has asked the U.S. courts to put a stop to actions by the journal Diabetes, which has issued expressions of concern over several of his papers. According to the lawsuit, obtained by the Boston Business Journal, Diabetes is looking into a number of papers by Mário Saad and may retract them.

“Most detrimental,” the complaint states, “the ADA [American Diabetes Association, which publishes Diabetes] stated that it will not consider, for publication in any ADA journal any submissions authored by any of the faculty of (Saad’s) University until the issues described in the expression of concern have been appropriately reviewed and addressed by the University.” 

Retraction Watch pointed out that last year Saad and colleagues pulled a 2009 paper published in Arquivos Brasileiros de Endocrinologia & Metabologia for plagiarism.

The recent expressions of concern regarding four papers in Diabetes were issued because of the possibility of manipulated or fabricated data. Saad’s institution conducted an investigation, which found, Saad told Retraction Watch, “only editing mistakes that can be corrected by erratum.” The Boston Business Journal reported that the American Diabetes Association has asked the university to re-open the investigation.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.